Poulvac Maternavac* IBD-Reo (Canada)This page contains information on Poulvac Maternavac* IBD-Reo for veterinary use.
The information provided typically includes the following:
- Poulvac Maternavac* IBD-Reo Indications
- Warnings and cautions for Poulvac Maternavac* IBD-Reo
- Direction and dosage information for Poulvac Maternavac* IBD-Reo
Poulvac Maternavac* IBD-ReoThis treatment applies to the following species:
Bursal Disease-Reovirus Vaccine
Standard and Variant, Killed Virus
For Veterinary Use Only
For the revaccination of healthy chickens as an aid in the prevention of the signs and lesions associated with infectious bursal disease caused by standard and variant strains and avian reovirus infections which cause malabsorption syndrome. As an aid for the prevention of signs and lesions associated with infectious bursal disease and reovirus disease via maternal antibodies in the progeny of vaccinates.
DOSE: Inject 0.5 mL (0.5 cc) intramuscularly or subcutaneously (in the lower neck region) using aseptic technique. Vaccinate only healthy birds. For primed birds, a single dose between 16 and 22 weeks (approximately 4 weeks prior to lay) is indicated.
Poulvac Maternavac* IBD-Reo Caution
Store in the dark at 2° to 7°C (35° to 45°F). Do not freeze. Warm to 22°C (72°F) and shake well before using. Do not vaccinate within 42 days before slaughter. Use entire contents when first opened.
Gentamicin and amphotericin B added as preservatives.
WarningIn case of accidental human injection seek immediate medical attention.
U.S. Vet. License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
16,740 TRANS-CANADA HIGHWAY, KIRKLAND, QC, H9H 4M7
|Technical Services Canada:||800-461-0917|
|Technical Services USA:||800-366-5288|
Copyright © 2022 Animalytix LLC. Updated: 2021-12-02